New Frontiers for Cancer Research

Saturday, October 22, 2022

Master of Ceremony: Mr. Lance Kawaguchi, Board Member of NFCR, Chairman of AFCR

Co-Hosted by  AIM-HI logo

8:45 – 8:55 am:

Opening and Welcome Remarks

Sujuan Ba, Ph.D., CEO of NFCR, Co-Founder of AIM-HI, & Founder of AFCR

Session I: Molecular Approaches to Understand and Treat Cancer

8:55 – 10:30 am:

Moderator: Web Cavenee, Ph.D., Chair of NFCR Scientific Advisory Board; Distinguished Professor of Medicine, University of California, San Diego and Director of Strategic Alliances, Ludwig Institute for Cancer Research

Panel Members:

  • Ken C. Anderson, M.D., Dana-Farber Cancer Institute, Professor of Medicine, Harvard; Physician Oncology, Brigham and Women’s Hospital
  • J. Silvio Gutkind Ph.D., Professor and Chair, Pharmacology, University of California, San Diego
  • Aaron N. Hata, M.D., Ph.D., Assistant Professor of Medicine, Harvard 
  • Isidore Rigoutsos, Ph.D., Professor in Computational Medicine, Thomas Jefferson University
  • Suzanne Topalian, M.D., Professor of Oncology and Surgery, Johns Hopkins University
  • Katherine Uyhazi, M.D., Ph.D., Assistant Professor of Ophthalmology, University of Pennsylvania

10:30 - 10:45 am: Coffee Break

Session II: New Approaches to Treat Breast, Pancreatic, and Head & Neck Cancer

10:45 am – 12:20 pm:

Moderator: Jennifer Grandis, M.D., American Cancer Society Professor of Otolaryngology, University of California, San Francisco

Panel Members: 

  • Lisa Coussens, Ph.D., Professor and Chair, Department of Cell, Developmental & Cancer Biology, Oregon Health and Sciences University
  • Daniel A. Haber, M.D., Ph.D., Director, Massachusetts General Hospital Cancer Center
  • Courtney Houchen, M.D., Professor, Chief of Digestive Diseases and Nutrition, Oklahoma  University School of Medicine
  • Daniel E. Johnson, Ph.D., Professor and Vice Chair of Research, Otolaryngology and Head and Neck Surgery, University of California, San Francisco
  • Kornelia Polyak, M.D., Ph.D., Professor of Medicine, Dana-Farber Cancer Institute, Harvard 
  • Xiang-Lei Yang, Ph.D., Professor of Molecular Biology and Medicine, Scripps Research

12:20 – 12:25 pm:

Closing Remarks: Alfred Slanetz, Ph.D. Chairman of Board of Directors, NFCR; CEO of Geneius Biotechnology

Special Thanks To Our Sponsors!

Sponsorship Opportunities

Inquiries regarding sponsorship for this event can be made by e-mail at or by phone at 1-800-321-CURE (2873).